Earth Science Tech Inc. (OTC: ETST) is reporting fiscal 2026 revenue growth of 8%, alongside increases in gross profit and net income, according to a company announcement. The growth is attributed to the company’s diversified, vertically integrated business model that spans pharmaceuticals, telemedicine, retail and real estate.
Through subsidiaries including Peak Curative, RxCompound and Mister Meds, Earth Science Tech connects telemedicine consultations, compounding pharmacies and medication fulfillment within an end-to-end healthcare ecosystem. Its MOCTeledoc platform also provides B2B technology and clinical staffing solutions, allowing the company to generate revenue by supporting other digital health companies while expanding its own reach.
The integrated model supports product development and diversification, contributing to the financial improvements. Earth Science Tech operates as a diversified holding company focused on the health and wellness sector. Its principal operating strategy is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The company’s healthcare operations are supported by investments in real estate and asset management activities and a consumer products business.
The core of the company’s value proposition is the seamless integration of patient care, from consultation to fulfillment. This is achieved through the synergy of specialized subsidiaries. For more information, visit www.EarthScienceTech.com.
To view the full article, visit https://ibn.fm/I1F0R. The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST.
